Guangzhou Boji Medical and Biotechnological Co Ltd (300404) — Working Capital to Net Assets Ratio
Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has a Working Capital to Net Assets ratio of 44.0% as of March 2026. Working capital of CN¥484.56 Million (current assets of CN¥1.01 Billion minus current liabilities of CN¥524.28 Million) is measured against net assets of CN¥1.10 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Guangzhou Boji Medical and Biotechnologi defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guangzhou Boji Medical and Biotechnological Co Ltd Working Capital to Net Assets (2015–2025)
This chart shows how Guangzhou Boji Medical and Biotechnological Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 44.0%, reflecting working capital of CN¥484.56 Million against net assets of CN¥1.10 Billion CNY. For the complete balance sheet picture, see Guangzhou Boji Medical and Biotechnologi asset portfolio.
Annual Working Capital to Net Assets for Guangzhou Boji Medical and Biotechnological Co Ltd (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guangzhou Boji Medical and Biotechnological Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Guangzhou Boji Medical and Biotechnologi's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 41.1% | CN¥435.40 Million | CN¥1.06 Billion | CN¥960.72 Million | CN¥525.33 Million | ▲ +2.9 pp |
| 2024 | 38.2% | CN¥382.76 Million | CN¥1.00 Billion | CN¥780.28 Million | CN¥397.51 Million | ▼ -8.5 pp |
| 2023 | 46.7% | CN¥457.67 Million | CN¥980.11 Million | CN¥815.18 Million | CN¥357.51 Million | ▲ +1.6 pp |
| 2022 | 45.1% | CN¥401.02 Million | CN¥888.72 Million | CN¥701.21 Million | CN¥300.19 Million | ▼ -5.6 pp |
| 2021 | 50.7% | CN¥429.26 Million | CN¥846.38 Million | CN¥700.10 Million | CN¥270.84 Million | ▲ +24.1 pp |
| 2020 | 26.6% | CN¥128.94 Million | CN¥485.00 Million | CN¥374.86 Million | CN¥245.91 Million | ▼ -0.9 pp |
| 2019 | 27.5% | CN¥125.52 Million | CN¥456.08 Million | CN¥286.43 Million | CN¥160.91 Million | ▲ +0.0 pp |
| 2018 | 27.5% | CN¥116.46 Million | CN¥423.71 Million | CN¥281.62 Million | CN¥165.16 Million | ▼ -13.4 pp |
| 2017 | 40.9% | CN¥169.28 Million | CN¥414.35 Million | CN¥321.35 Million | CN¥152.07 Million | ▼ -14.3 pp |
| 2016 | 55.1% | CN¥237.00 Million | CN¥429.84 Million | CN¥320.12 Million | CN¥83.13 Million | ▼ -20.6 pp |
| 2015 | 75.7% | CN¥327.68 Million | CN¥432.68 Million | CN¥408.94 Million | CN¥81.26 Million | — |